Comparing the risk of deep vein thrombosis of two combined oral contraceptives: Norethindrone/ethinyl estradiol and drospirenone/ethinyl estradiol

Background: Deep vein thrombosis (DVT) has been reported as an adverse event for patients receiving combined oral contraceptives. Norethindrone/ethinyl estradiol (NET/EE) and drospirenone/ethinyl estradiol (DRSP/EE) are two commonly prescribed combined hormonal oral contraceptive agents used in the...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Jennifer Stalas, Robert Morris, Kun Bu, Kevin von Bargen, Rebekah Largmann, Kathryn Sanford, Jacob Vandeventer, Weiru Han, Feng Cheng
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2024-03-01
Edice:	Heliyon
Témata:	FAERS DVT DRSP Pharmacovigilance Drug-drug interactions DDI
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2405844024024939
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!